Innoviva, Inc. — Director's Dealing 2014

Dec 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2014-12-22

Reporting Person: PEPE PAUL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-22	Common Stock	A	6500	—	Acquired	21670	Direct

Footnotes

F1: The Reporting Person was granted restricted stock units ("RSUs"). Seventy-five percent of the RSUs will vest and will be delivered to the Reporting Person upon the 2015 annual meeting of the Issuer and the remaining twenty-five percent of the RSUs will vest and will be delivered to the Reporting Person upon the 2016 annual meeting of the Issuer.